A representative from the Drug Enforcement Administration (DEA) has expressed the agency’s intention to dispel any misunderstandings surrounding its drug scheduling review process, emphasizing a commitment to transparency. The DEA is currently in the process of potentially reclassifying marijuana and aims to ensure clarity in its decision-making.
New Jersey’s THC beverage market is heading into the most consequential stretch of its short…
Mormon Wives star Mikayla Matthews says medical cannabis was “literally life-changing” for her nerve pain…
Chains reorder every two weeks and earn twice the discounts. Independents stock the same breadth…
We head to Canna Country Farms in Humboldt for Legendary Strains to discover the Ocimene…
Cannabis advocates should take the lesson here too. The industry doesn't need to inflate its…
Twenty patient associations from across northeastern Brazil are meeting in Fortaleza this month, inside a…